Fierce Biotech Summit
September 19-20, 2022
FUJIFILM Diosynth Biotechnologies is delighted to be a sponsor at Fierce Biotech Summit, September 19-20, 2022, Boston, MA. Stop by booth 7 and meet with our team to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines.
Join September 19, 2022 @ 9:15am EDT
Christine Vannais, Chief Operating Officer, FUJIFILM Diosynth Biotechnologies, Research Triangle Park,NC is delivering the Partner Ketnote speakin on: Innovations in BioManufacturing, a CDMO perspective
- This year marks the 40th year of the approval of the first FDA approve biotechnology drug. Our industry has evolved tremendously and we have seen incredible changes to make life impacting medicines available.
- We have seen an evolution and expansion in the modalities that are going through the drug development life cycle. Biomanufacturing needs to be ready with the required infrastructure, innovation, flexibility and expertise to deliver these treatments.
- CDMOs, such as FUJIFILM Diosynth Biotechnologies, are implementing innovations that will drive the future of Biomanufacturing. Innovation in the CDMO spaces, can be different than innovation from discovery and molecule ownership and will bring different value.